PT1394272E - Metodo para deteccao de mutuaoes em ki-ras - Google Patents

Metodo para deteccao de mutuaoes em ki-ras

Info

Publication number
PT1394272E
PT1394272E PT03020560T PT03020560T PT1394272E PT 1394272 E PT1394272 E PT 1394272E PT 03020560 T PT03020560 T PT 03020560T PT 03020560 T PT03020560 T PT 03020560T PT 1394272 E PT1394272 E PT 1394272E
Authority
PT
Portugal
Prior art keywords
detecting
ras
mutuals
pcr
tissue
Prior art date
Application number
PT03020560T
Other languages
English (en)
Portuguese (pt)
Inventor
Ulrik Arve
Koornstra Jan Jacob
Ogreid Dagfinn
Original Assignee
Nordiag As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordiag As filed Critical Nordiag As
Publication of PT1394272E publication Critical patent/PT1394272E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Saccharide Compounds (AREA)
  • Holo Graphy (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
PT03020560T 1995-11-17 1996-11-15 Metodo para deteccao de mutuaoes em ki-ras PT1394272E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO954667A NO954667D0 (no) 1995-11-17 1995-11-17 Fremgangsmåte til deteksjon av Ki-ras mutasjoner

Publications (1)

Publication Number Publication Date
PT1394272E true PT1394272E (pt) 2006-07-31

Family

ID=19898772

Family Applications (2)

Application Number Title Priority Date Filing Date
PT03020560T PT1394272E (pt) 1995-11-17 1996-11-15 Metodo para deteccao de mutuaoes em ki-ras
PT96939373T PT868529E (pt) 1995-11-17 1996-11-15 Metodo para deteccao de mutacoes em ki-ras e "kit" para a sua realizacao

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT96939373T PT868529E (pt) 1995-11-17 1996-11-15 Metodo para deteccao de mutacoes em ki-ras e "kit" para a sua realizacao

Country Status (12)

Country Link
US (1) US6440661B1 (OSRAM)
EP (2) EP1394272B1 (OSRAM)
JP (1) JP2000500346A (OSRAM)
AT (2) ATE251222T1 (OSRAM)
AU (1) AU723980C (OSRAM)
DE (2) DE69635848T2 (OSRAM)
DK (2) DK1394272T3 (OSRAM)
ES (2) ES2262930T3 (OSRAM)
NO (2) NO954667D0 (OSRAM)
NZ (1) NZ322619A (OSRAM)
PT (2) PT1394272E (OSRAM)
WO (1) WO1997019191A1 (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715034D0 (en) * 1997-07-18 1997-09-24 Zeneca Ltd Assay
DE60029092T2 (de) * 1999-04-09 2007-02-01 Exact Sciences Corp., Marlborough Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
US6531302B1 (en) * 1999-04-12 2003-03-11 Nanogen/Becton Dickinson Partnership Anchored strand displacement amplification on an electronically addressable microchip
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
CA2394921A1 (en) 1999-12-07 2001-06-14 Anthony P. Shuber Supracolonic aerodigestive neoplasm detection
US7087414B2 (en) 2000-06-06 2006-08-08 Applera Corporation Methods and devices for multiplexing amplification reactions
EP2351853A1 (en) * 2000-06-06 2011-08-03 Life Technologies Corporation Method and devices for multiplexing amplification reactions
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
JP2006508662A (ja) 2002-12-04 2006-03-16 アプレラ コーポレイション ポリヌクレオチドの多重増幅
US20080124714A1 (en) * 2004-05-14 2008-05-29 Exact Sciences Corporation Method for Stabilizing Biological Samples for Nucleic Acid Analysis
US20070134709A1 (en) * 2005-12-14 2007-06-14 Xiping Xu Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
GB2435512A (en) 2006-02-23 2007-08-29 Mologic Ltd A binding assay and assay device
CN101449162B (zh) 2006-05-18 2013-07-31 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
EP2318552B1 (en) 2008-09-05 2016-11-23 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
EP2730662A1 (en) 2008-11-12 2014-05-14 Caris Life Sciences Luxembourg Holdings Methods and systems of using exosomes for determining phenotypes
WO2011082321A1 (en) * 2009-12-31 2011-07-07 Van Andel Research Institute Methods for diagnosing the malignant potential of pancreatic cystic lesions
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
BR112012025593A2 (pt) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings biomarcadores em circulação para doença
CA2810931C (en) 2010-09-24 2018-04-17 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target dna using immobilized primers
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
CN102796811B (zh) * 2011-05-26 2013-12-18 上海赛安生物医药科技有限公司 检测kras突变的试剂及方法
EP2721140B1 (en) 2011-06-19 2016-11-23 Abogen, Inc. Devices, solutions and methods for sample collection
EP2780473B1 (en) * 2011-11-17 2017-07-19 The Johns Hopkins University Differential identification of pancreatic cysts
WO2014085826A2 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors
SG11201607364RA (en) 2014-03-07 2016-10-28 Dna Genotek Inc Composition and method for stabilizing nucleic acids in biological samples
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス,インク. 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan
TW202015719A (zh) 2018-06-19 2020-05-01 美商尼恩醫療公司 新抗原及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871838A (en) * 1985-07-23 1989-10-03 The Board Of Rijks Universiteit Leiden Probes and methods for detecting activated ras oncogenes
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
IL97222A (en) * 1990-02-16 1995-08-31 Orion Yhtymae Oy Method and reagent for determining specific nucleotide variations
ATE253645T1 (de) 1992-04-01 2003-11-15 Univ Johns Hopkins Med Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
JP2001507921A (ja) * 1992-04-27 2001-06-19 トラスティーズ オブ ダートマス カレッジ 生物学的液体中の遺伝子配列の検出
JPH06167492A (ja) * 1992-11-30 1994-06-14 Otsuka Pharmaceut Co Ltd 変異癌遺伝子の検出測定方法
DE19512369A1 (de) * 1995-04-01 1996-10-02 Boehringer Mannheim Gmbh Vorrichtung zur Isolierung von Nukleinsäuren

Also Published As

Publication number Publication date
JP2000500346A (ja) 2000-01-18
DE69635848T2 (de) 2006-11-30
AU723980C (en) 2002-10-24
EP1394272B1 (en) 2006-03-01
DK1394272T3 (da) 2006-07-03
DK0868529T3 (da) 2004-02-02
DE69630234D1 (de) 2003-11-06
ATE318934T1 (de) 2006-03-15
ATE251222T1 (de) 2003-10-15
NO982246D0 (no) 1998-05-15
AU723980B2 (en) 2000-09-07
WO1997019191A1 (en) 1997-05-29
AU7656996A (en) 1997-06-11
ES2262930T3 (es) 2006-12-01
NO954667D0 (no) 1995-11-17
EP0868529A1 (en) 1998-10-07
EP0868529B1 (en) 2003-10-01
ES2208766T3 (es) 2004-06-16
DE69635848D1 (de) 2006-04-27
NZ322619A (en) 1999-04-29
PT868529E (pt) 2004-02-27
EP1394272A1 (en) 2004-03-03
DE69630234T2 (de) 2004-08-19
NO324963B1 (no) 2008-01-14
US6440661B1 (en) 2002-08-27
NO982246L (no) 1998-07-07

Similar Documents

Publication Publication Date Title
PT1394272E (pt) Metodo para deteccao de mutuaoes em ki-ras
AU9058091A (en) Preparation of nucleic acid samples
DE60238493D1 (de) Is von seltenen zellen verwendete markierte zellen
DK0518650T3 (da) Sekvensspecifik DNA-binding med p53
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
EP0357611A4 (en) A method of detection of carcinogenic human papillomavirus
DE69728236D1 (de) Vorrichtung zur non-invasiven Bestimmung der Glukosekonzentration im Blut
GB9001181D0 (en) Genetic assay
AU1272000A (en) Method for the quantitative detection of nucleic acids
DE69019886D1 (de) Katheter und Instrumentarium zur extrakorporalen Zirkulation.
EP0419502A4 (en) Method of detecting bacteria in urine
DK1228241T3 (da) Genetisk test til at bestemme non-responsevne på statinlægemiddelbehandling
ITRM920491A0 (it) Immunodosaggio di enzima b12 e procedimento di trattamento di campioniper esso.
AU2002364302A1 (en) Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
DE69531505D1 (de) Verfahren zur zellerkennung
AU2283792A (en) Direct detection of hepatitis c virus rna
AU1720497A (en) Use of primers for universal fingerprint analysis
ATE403716T1 (de) Nukleinsäure und korrespondierendes protein 85p1b3, nützlich zur behandlung und detektion von krebserkrankungen
EP0497820A4 (en) Ribozyme inhibitors
DE60224778D1 (de) Zusammensetzungen und Verfahren zur Behandlung und zur Detektion von proliferativen Störungen die mit der Überexpression des menschlichen "Transketolase like-1" gens in Zusammenhang stehen
DE69813181D1 (de) Icam-4 und dessen diagnostische verwendungen
FR2729823B1 (fr) Conservation de prelevements de sang, en particulier chez les malades traites par l'heparine
WO1999051531A8 (en) Waste treatment system and method
GB2256271A (en) Genetic assay for cytochrome p450